While NK cells, CD4+ and CD8+ T cells, dendritic cells (DC) and pro-inflammatory M1 macrophages promote anti-tumor immune responses, heterogeneous populations of myeloid-derived suppressor cells (MDSC), FOXP3+ regulatory T cells and M2 macrophages counteract tumor immunity [23,31]. This evidence concerns the gene CD4 and neoplasm.